REFERENCES
- Weinstein L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol 1982; 142: 159–67
- Weinstein L. Preeclampsia/eclampsia with hemolysis, elevated liver enzymes, and thrombocytopenia. Obstet Gynecol 1985; 66: 657–60
- Sibai B M, Taslimi M M, El-Mazer A, Amon E, Mabie B C, Ryan G M. Maternal perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes and low platelets in severe preeclampsia-eclampsia. Am J Obstet Gynecol 1986; 155: 501–9
- Reubinoff B E, Schenker J G. HELLP syndrome—a syndrome of hemolysis, elevated liver enzymes and low platelet count—complicating pre-eclampsia–eclampsia. Int J Gynecol Obstet 1991; 36: 95–102
- Geary M. The HELLP syndrome. Br J Obstet Gynaecol 1997; 104: 887–91
- Sibai B M. The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): much ado about nothing?. Am J Obstet Gynecol 1990; 162: 311–16
- Audibert F, Friedman S A, Frangieh A Y, Sibai B M. Clinical utility of strict diagnostic criteria for the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol 1996; 175: 460–64
- Visser W, Wallenburg H CS. Temporising management of severe preeclampsia with and without the HELLP syndrome. Br J Obstet Gynaecol 1995; 102: 111–17
- Pampus van M G, Wolf H, Westenberg S M, Post van der J AM, Bonsel G J, Treffers P E. Maternal and perinatal outcome after expectant management of the HELLP syndrome compared with pre-eclampsia without HELLP syndrome. Eur J Obstet Gynecol Reprod Biol 1998; 76: 31–36
- Martin J N, Perry K G, Miles J F, Blake P G, Magann E F, Roberts W E, et al. The interrelationship of eclampsia, HELLP syndrome, and prematurity: cofactors for significant maternal and perinatal risk. Br J Obstet Gynaecol 1993; 100: 1095–100
- Martin J N, Blake P G, Perry K G, McCaul J F, Hess L W, Martin R W. The natural history of HELLP syndrome: patterns of disease progression and regression. Am J Obstet Gynecol 1991; 164: 1500–9
- Schaap A HP, Wolf H, Bruinse H W, Leeuw de R, Ertbruggen van I, Treffers P E. Fetal distress due to placental insufficiency at 26 through 31 weeks: a comparison between an active and a more conservative management. Eur J Obstet Gynecol Reprod Biol 1996; 70: 61–8
- Sibai B M, Ramadan M K, Usta I, Salama M, Mercer B M, Friedman S A. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol 1993; 169: 1000–6
- Visser W, Pampus van M G, Treffers P E, Wallenburg H. Perinatal results of hemodynamic and conservative temporizing treatment in severe preeclampsia. Eur J Obstet Gynecol Reprod Biol 1994; 53: 175–81
- Thiagarajah S, Bourgeois J, Harber G, Caudle M. Thrombocytopenia in preeclampsia: associated abnormalities and management principles. Am J Obstet Gynecol 1984; 150: 1–7
- Goodlin R C. HELLP does not always mean immediate HELLP. Am J Obstet Gynecol 1990; 63: 1089
- Odendaal H J, Pattinson R C, Bam R, Grove D, Kotze T J. Aggressive or expectant management for patients with severe preecampsia between 28–34 weeks'gestation: a randomized controlled trial. Obstet Gynecol 1990; 76: 1070–5
- Sibai B M, Mercer B M, Schiff E, Friedman S A. Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: a randomized controlled trial. Am J Obstet Gynecol 1994; 171: 818–22